scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1039585686 |
P356 | DOI | 10.1186/S13028-016-0274-8 |
P8608 | Fatcat ID | release_yc4aqo7ktfg6zgamqxgfrgs4hq |
P932 | PMC publication ID | 5210291 |
P698 | PubMed publication ID | 28049540 |
P50 | author | Odd V. Höglund | Q47228210 |
Ragnvi Hagman | Q86915059 | ||
Thanikul Srithunyarat | Q87631164 | ||
P2093 | author name string | Ann Pettersson | |
Anne-Sofie Lagerstedt | |||
Mats Stridsberg | |||
Supranee Jitpean | |||
Ulf Olsson | |||
P2860 | cites work | The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses | Q24301790 |
Chromogranins can be measured in samples from cats and dogs | Q28241407 | ||
Chromogranin A and cortisol at intraoperative repeated noxious stimuli: Surgical stress in a dog model | Q28272056 | ||
Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2 | Q28474794 | ||
The novel chromogranin A-derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β-adrenergic-like inotropes | Q28579371 | ||
A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A. | Q33197177 | ||
Biological function and clinical relevance of chromogranin A and derived peptides | Q33574106 | ||
Circadian variations in salivary chromogranin a concentrations during a 24-hour period in dogs | Q33612155 | ||
Catestatin: a multifunctional peptide from chromogranin A | Q33838302 | ||
Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology | Q33909582 | ||
The stress response to trauma and surgery | Q33912460 | ||
The metabolic response to stress: an overview and update | Q34224833 | ||
Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga364–384) | Q34376655 | ||
Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heart | Q34388245 | ||
Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra). | Q35053232 | ||
Can biomarkers differentiate pain and no pain subgroups of nonverbal children with cerebral palsy? A preliminary investigation based on noninvasive saliva sampling | Q35096186 | ||
Chromogranin A: Novel biomarker between periodontal disease and psychosocial stress | Q37020274 | ||
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist | Q37372768 | ||
The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury. | Q37375312 | ||
A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis. | Q37431049 | ||
The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions | Q37565986 | ||
Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin | Q37698704 | ||
Diagnostic potential of saliva: current state and future applications | Q37850622 | ||
Chromogranin-A: a multifaceted cardiovascular role in health and disease | Q38029736 | ||
Chromogranin A as a biomarker in cardiovascular disease | Q38170143 | ||
Evaluation of psychosomatic stress in children by measuring salivary chromogranin A. | Q39134350 | ||
Effect of laughter on salivary endocrinological stress marker chromogranin A. | Q39335314 | ||
Antibacterial peptides are present in chromaffin cell secretory granules. | Q41735756 | ||
The catecholamine release-inhibitory peptide catestatin (chromogranin A344-363) modulates myocardial function in fish | Q42478440 | ||
Chromogranin A: Secretion of Processed Products from the Stimulated Retrogradely Perfused Bovine Adrenal Gland | Q42483774 | ||
Levels of awakening salivary CgA in response to stress in healthy subjects | Q42718182 | ||
Plasma levels and potential roles of catestatin in patients with coronary heart disease | Q43442071 | ||
Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin | Q43502817 | ||
Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure | Q43632766 | ||
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion | Q43681165 | ||
N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries | Q43915917 | ||
Measurement of chromogranin A in porcine saliva: validation of a time-resolved immunofluorometric assay and evaluation of its application as a marker of acute stress. | Q43946702 | ||
Vasostatins exert negative inotropism in the working heart of the frog. | Q44220649 | ||
Sources of sampling variation in saliva cortisol in dogs | Q44533902 | ||
Saliva collection by using filter paper for measuring cortisol levels in dogs | Q44902627 | ||
Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action | Q45098500 | ||
Ultradian variations of chromogranin A in humans. | Q45940145 | ||
Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. | Q45956186 | ||
Relationship between salivary Chromogranin-A and stress induced by simulated monotonous driving | Q46132764 | ||
Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance | Q46385483 | ||
The effects of examination stress on salivary cortisol, immunoglobulin A, and chromogranin A in nursing students | Q46413492 | ||
Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance | Q46691940 | ||
Measurement of plasma chromogranin A concentrations for assessment of stress responses in dogs with insulin-induced hypoglycemia | Q46793663 | ||
Chromogranin A measurement in neuroendocrine tumors | Q47778458 | ||
Different chromogranin immunoreactivity between prion and a-beta amyloid plaque | Q48337156 | ||
Extreme exercise enhances chromogranin A levels correlating with stress levels but not with cardiac burden. | Q48809821 | ||
Plasma levels and diagnostic value of catestatin in patients with heart failure. | Q50966067 | ||
The Neuropeptide Catestatin Acts As a Novel Angiogenic Cytokine via a Basic Fibroblast Growth Factor–Dependent Mechanism | Q54645179 | ||
Chromogranin A: is it a useful marker of neuroendocrine tumors? | Q56995217 | ||
Production and Structure Characterization of Recombinant Chromogranin A N-Terminal Fragments (Vasostatins). Evidence of Dimmer-Monomer Equilibria | Q57951029 | ||
Secretion of a Chromaffin Granule Protein, Chromogranin, from the Adrenal Gland after Splanchnic Stimulation | Q59071070 | ||
Increases in heart rate and serum cortisol concentrations in healthy dogs are positively correlated with an indoor waiting-room environment | Q61995945 | ||
Saliva chromogranin A in growing pigs: A study of circadian patterns during daytime and stability under different storage conditions | Q62206709 | ||
The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels | Q67596111 | ||
Autocrine inhibition of parathyroid cell secretion requires proteolytic processing of chromogranin A | Q68193285 | ||
Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments | Q70485024 | ||
Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma | Q70596778 | ||
Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites | Q72563888 | ||
Processing of chromogranin A in the parathyroid: generation of parastatin-related peptides | Q73173932 | ||
Salivary secretion of highly concentrated chromogranin a in response to noradrenaline and acetylcholine in isolated and perfused rat submandibular glands | Q73189898 | ||
Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats | Q73421488 | ||
Immunohistochemical localization of chromogranin a in the acinar cells of equine salivary glands contrasts with rodent glands | Q78329848 | ||
Processing-independent quantitation of chromogranin a in plasma from patients with neuroendocrine tumors and small-cell lung carcinomas | Q79677825 | ||
Circadian rhythm of human salivary chromogranin A | Q80019784 | ||
Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumors | Q81262425 | ||
Expression and localization of chromogranin A gene and protein in human submandibular gland | Q81580114 | ||
Catestatin is useful in detecting patients with stage B heart failure | Q82327587 | ||
Plasma chromogranin A after severe burn trauma | Q85599113 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1 | |
P577 | publication date | 2017-01-03 | |
P1433 | published in | Acta Veterinaria Scandinavica | Q15763576 |
P1476 | title | Catestatin and vasostatin concentrations in healthy dogs | |
P478 | volume | 59 |
Q36317629 | Catestatin, vasostatin, cortisol, and pain assessments in dogs suffering from traumatic bone fractures |
Q28277584 | Catestatin, vasostatin, cortisol, temperature, heart rate, respiratory rate, scores of the short form of the Glasgow composite measure pain scale and visual analog scale for stress and pain behavior in dogs before and after ovariohysterectomy |
Search more.